JM el-Dahr, R Fink, R Selden, LK Arruda, TA Platts-Mills and PW Heymann
Department of Pediatrics, University of Virginia, Charlottesville.

Although the ability of Aspergillus organisms to colonize the respiratory tract in patients with cystic fibrosis (CF) is well recognized, the contribution of Aspergillus to the disease process is poorly understood. Using sera from 147 CF patients (age 5 to 43 yr), we measured IgE antibody (ab) to Aspergillus fumigatus and five common inhalant allergens with a radioallergosorbent test (RAST). Total IgE levels and IgG ab to radio-labeled Asp f I, an allergen purified from A. fumigatus and a potent inhibitor of protein synthesis, were also measured. Thirty (20%) of the patients had IgE ab to A. fumigatus, and 22 (15%) of these patients had developed total IgE levels > or = 400 IU/ml, raising the consideration of a diagnosis of allergic bronchopulmonary aspergillosis (ABPA). Five of the 22 patients developed these IgE responses by age 5 yr and 14 by age 10 yr. The proportion of patients with IgE ab to one or more of the other allergens tested was not significantly different from that of control subjects without respiratory symptoms. A striking proportion (84%) of CF sera contained IgG ab to Asp f I, compared with 6% of sera from control patients and 20% of sera from allergic children with asthma (n = 25), only one of whom had IgE ab to A. fumigatus. In an examination of additional sera from young CF patients, IgG anti-Asp f I ab was detected in 41% of these sera from patients 5 yr of age or older, increasing to 98% of 89 sera from patients older than age 10.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				C. K van der Ent, H. Hoekstra, and G. T Rijkers Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody Thorax, March 1, 2007; 62(3): 276 - 277. [Abstract] [Full Text] [PDF]

				R. Kraemer, N. Delosea, P. Ballinari, S. Gallati, and R. Crameri Effect of Allergic Bronchopulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1211 - 1220. [Abstract] [Full Text] [PDF]

				E. Van Hoeyveld, L. Dupont, and X. Bossuyt Quantification of IgG Antibodies to Aspergillus fumigatus and Pigeon Antigens by ImmunoCAP Technology: An Alternative to the Precipitation Technique? Clin. Chem., September 1, 2006; 52(9): 1785 - 1793. [Abstract] [Full Text] [PDF]

				W. H. Nikolaizik, M. Weichel, K. Blaser, and R. Crameri Intracutaneous Tests with Recombinant Allergens in Cystic Fibrosis Patients with Allergic Bronchopulmonary Aspergillosis and Aspergillus Allergy Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 916 - 921. [Abstract] [Full Text] [PDF]

				L. Maiz, M. Cuevas, S. Quirce, J. F. Canon, A. Pacheco, A. Sousa, and H. Escobar Serologic IgE Immune Responses Against Aspergillus fumigatus and Candida albicans in Patients With Cystic Fibrosis Chest, March 1, 2002; 121(3): 782 - 788. [Abstract] [Full Text] [PDF]

				M. Weig, M. Frosch, K. Tintelnot, A. Haas, U. Groß, B. Linsmeier, and J. Heesemann Use of Recombinant Mitogillin for Improved Serodiagnosis of Aspergillus fumigatus-Associated Diseases J. Clin. Microbiol., May 1, 2001; 39(5): 1721 - 1730. [Abstract] [Full Text]

				E. Marchand, C. Verellen-Dumoulin, M. Mairesse, L. Delaunois, P. Brancaleone, J.-F. Rahier, and O. Vandenplas Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations and 5T Allele in Patients With Allergic Bronchopulmonary Aspergillosis Chest, March 1, 2001; 119(3): 762 - 767. [Abstract] [Full Text] [PDF]

				J.A. Kastelik, I. Aziz, A.E. Redington, and A.H. Morice Allergic bronchopulmonary aspergillosis in cystic fibrosis Eur. Respir. J., January 1, 2001; 17(1): 156 - 156. [Full Text] [PDF]

				D. E. Geller, H. Kaplowitz, M. J. Light, and A. A. Colin Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: Reported Prevalence, Regional Distribution, and Patient Characteristics Chest, September 1, 1999; 116(3): 639 - 646. [Abstract] [Full Text] [PDF]

				I. B. Nepomuceno, S. Esrig, and R. B. Moss Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: Role of Atopy and Response to Itraconazole Chest, February 1, 1999; 115(2): 364 - 370. [Abstract] [Full Text] [PDF]

				M Skov, T Pressler, H E Jensen, N Høiby, and C Koch Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA) Thorax, January 1, 1999; 54(1): 44 - 50. [Abstract] [Full Text]